Rallybio Corp Faces Delisting Concerns
Ticker: RLYB · Form: 8-K · Filed: Aug 29, 2025 · CIK: 1739410
| Field | Detail |
|---|---|
| Company | Rallybio Corp (RLYB) |
| Form Type | 8-K |
| Filed Date | Aug 29, 2025 |
| Risk Level | high |
| Pages | 2 |
| Reading Time | 3 min |
| Key Dollar Amounts | $0.0001, $1.00 |
| Sentiment | bearish |
Sentiment: bearish
Topics: delisting, compliance, exchange-listing
TL;DR
Rallybio might get kicked off NASDAQ. Big trouble.
AI Summary
Rallybio Corporation filed an 8-K on August 29, 2025, reporting a notice of delisting or failure to satisfy a continued listing rule or standard. The filing indicates potential issues with maintaining its listing on the NASDAQ exchange as of August 26, 2025. The company is incorporated in Delaware and its principal executive offices are located in New Haven, Connecticut.
Why It Matters
This filing signals potential financial distress or non-compliance with exchange rules, which could significantly impact investor confidence and the company's ability to raise capital.
Risk Assessment
Risk Level: high — A notice of delisting directly threatens the company's public trading status, creating significant uncertainty and potential financial instability.
Key Players & Entities
- Rallybio Corporation (company) — Registrant
- NASDAQ (company) — Stock Exchange
- August 26, 2025 (date) — Earliest event reported
- August 29, 2025 (date) — Filing date
- Delaware (jurisdiction) — State of Incorporation
- New Haven, Connecticut (location) — Principal Executive Offices
FAQ
What specific rule or standard has Rallybio Corporation failed to satisfy for its continued listing on NASDAQ?
The filing does not specify the exact rule or standard that Rallybio Corporation has failed to satisfy, only that a notice of delisting or failure to satisfy a continued listing rule or standard has been issued.
What is the effective date of the potential delisting or the event triggering this notice?
The earliest event reported in relation to this notice was on August 26, 2025.
Has Rallybio Corporation taken any steps to address the delisting concerns?
The provided text of the 8-K filing does not contain information about any steps Rallybio Corporation has taken to address the delisting concerns.
What is the Commission File Number for Rallybio Corporation?
The Commission File Number for Rallybio Corporation is 001-40693.
When was Rallybio Corporation incorporated and in which state?
Rallybio Corporation was incorporated in Delaware.
Filing Stats: 691 words · 3 min read · ~2 pages · Grade level 14 · Accepted 2025-08-29 16:05:26
Key Financial Figures
- $0.0001 — ich registered Common Stock, par value $0.0001 per share RLYB NASDAQ Capital Marke
- $1.00 — below the minimum closing bid price of $1.00 per share during the prior 30 consecuti
Filing Documents
- d239571d8k.htm (8-K) — 26KB
- 0001193125-25-192749.txt ( ) — 141KB
- rlyb-20250826.xsd (EX-101.SCH) — 3KB
- rlyb-20250826_lab.xml (EX-101.LAB) — 18KB
- rlyb-20250826_pre.xml (EX-101.PRE) — 11KB
- d239571d8k_htm.xml (XML) — 4KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized. RALLYBIO CORPORATION Date: August 29, 2025 By: /s/ Jonathan I. Lieber Jonathan I. Lieber Chief Financial Officer and Treasurer